WILMINGTON, DE — AOP Health US, LLC has been awarded a national group purchasing agreement with Premier, Inc., allowing Premier members to access pre-negotiated pricing and terms for Rapiblyk (landiolol), the company announced.
The agreement enables participating health care providers to purchase the drug under terms negotiated by Premier, according to AOP Health US.
Rapiblyk is approved by the U.S. Food and Drug Administration for the short-term reduction of ventricular rate in adults with supraventricular tachycardia, including atrial fibrillation and atrial flutter, in critical care settings.
The medication is administered as an intravenous infusion in monitored hospital environments, the company said.
Premier, headquartered in Charlotte, North Carolina, operates a group purchasing organization that negotiates contracts on behalf of hospitals and other health care providers.
John Kimmet, general manager of AOP Health US, said the agreement supports broader availability of the drug in critical care environments.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.